Characterization of the Genetic Environment of the blaVEB-4 Gene, Associated with a Transposable Region in a Proteus mirabilis Clinical Isolate

Microb Drug Resist. 2017 Oct;23(7):833-837. doi: 10.1089/mdr.2016.0262. Epub 2017 Mar 17.

Abstract

Proteus mirabilis is the second most common cause of urinary tract infections and is also an important cause of nosocomial infections. TEM-type and CTX-M-type extended-spectrum β-lactamases (ESBLs) are the most widely distributed in this bacterial species, but minor ESBLs such as the VEB-type have also been identified. The aim of this study was to analyze the genetic environment of the blaVEB-4 gene found in a P. mirabilis clinical isolate recovered in Spain. P. mirabilis N2231 showed resistance to penicillins, cephalosporins, and aminoglycosides, remaining susceptible to imipenem, cefoxitin, β-lactamases inhibitors, and quinolones. Southern blot analysis revealed that blaVEB-4 was located in the chromosome. Analysis of the blaVEB-4 genetic context revealed a 15 kb segment 98% identical to the multidrug resistance (MDR) region of a Salmonella genomic island 1 (SGI1), which included a class 1 integron belonging to the In104 family, previously described in blaVEB-6-producing P. mirabilis VB1248. blaVEB-4 was surrounded by repeat elements, transposon Tn1721, and located on a class 1 integron containing aacA4-aadB-dfrA1-orfC genes. The blaVEB-4 gene was inserted in a complex structure of a class 1 integron, which is part of an MDR region of an SGI1, possibly involved in the mobilization of the gene and homologous recombination.

Keywords: VEB enzymes; class A β-lactamases; transposon Tn1721.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Chromosome Mapping
  • Chromosomes, Bacterial / chemistry*
  • Chromosomes, Bacterial / metabolism
  • Cross Infection / drug therapy
  • Cross Infection / microbiology
  • DNA Transposable Elements
  • Drug Resistance, Multiple, Bacterial / genetics*
  • Gene Expression
  • Humans
  • Integrons*
  • Microbial Sensitivity Tests
  • Microsatellite Repeats
  • Proteus Infections / drug therapy
  • Proteus Infections / microbiology
  • Proteus mirabilis / drug effects
  • Proteus mirabilis / enzymology
  • Proteus mirabilis / genetics*
  • Proteus mirabilis / isolation & purification
  • Spain
  • Urinary Tract Infections / drug therapy
  • Urinary Tract Infections / microbiology
  • beta-Lactamases / genetics*
  • beta-Lactamases / metabolism

Substances

  • Anti-Bacterial Agents
  • DNA Transposable Elements
  • beta-Lactamases